By - Reuters
* Gamida Cell Ltd is expected to show no change in quarterly revenue when it reports results on March 27. * * ​Refinitiv's mean analyst estimate for Gamida Cell Ltd is for a loss of 25 cents per share. * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." * The mean earnings estimate of analysts was unchanged in the last three months. ​ * Wall Street's median 12-month price target for Gamida Cell Ltd is $10​, above​ its last closing price of $1.30. ​​​ Previous quarterly performance (using preferred earnings measure in US dollars). ​ QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI ENDING ARTESTIMAT IBES MET, SE % E® ESTIMATE MISSED Sep. 30 2022 -0.31 -0.31 -0.29 Beat 5.2 Jun. 30 2022 -0.29 -0.29 -0.31 Missed -6.2 Mar. 31 2022 -0.34 -0.34 -0.34 Met 0​ Dec. 31 2021 -0.40 -0.40 -0.52 Missed -28.4 ​​Sep. -0.49 -0.48 -0.33 Beat 31.3 30 2021 Jun. 30 2021 -0.39 -0.40 -0.36 Beat 10.4​ Mar. 31 2021 -0.40 -0.40 -0.31 Beat 22.2 Dec. 31 2020 -0.34 -0.34 -0.68 Missed -98.1 This summary was machine generated March 24 at 12:55 GMT. All figures in US dollars unless otherwise stated.